SEQUA Stock Financial Analysis - Sequana Medical NV (ENXTBR) Stock

Overview

Sequana Medical N.V. is a Belgian-based medical technology company specializing in the development and commercialization of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. The company's flagship project is the alfapump®, a fully implantable, programmable, and wirelessly charged system designed to remove excess fluid from the abdominal cavity. Sequana Medical is also developing the Direct Sodium Removal (DSR) therapy, a potential breakthrough treatment for volume overload in heart failure.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Sequana Medical NV as of 31 December 2024 is 0.11 MM.
The operating income for Sequana Medical NV as of 31 December 2024 is -18.71 MM.
The net income for Sequana Medical NV as of 31 December 2024 is -44.65 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2024-12-31	0.11	-18.71	-44.65
2024-09-30	0.27	-21.19	-35.92
2024-06-30	0.43	-23.67	-27.18
2024-03-31	0.57	-26.58	-29.87
2023-12-31	0.71	-29.49	-32.56
2023-09-30	0.78	-30.12	-32.47
2023-06-30	0.84	-30.75	-32.37
2023-03-31	0.88	-29.69	-31.57
2022-12-31	0.92	-28.62	-30.76
2022-09-30	0.87	-27.12	-28.67
2022-06-30	0.81	-25.62	-26.58
2022-03-31	0.59	-24.72	-25.10
2021-12-31	0.37	-23.82	-23.62
2021-09-30	0.38	-22.07	-22.53
2021-06-30	0.39	-20.33	-21.44
2021-03-31	0.68	-19.05	-20.27
2020-12-31	0.96	-17.77	-19.11
2020-09-30	1.06	-16.91	-18.17
2020-06-30

Income Statement: EPS

The earnings per share basic for Sequana Medical NV as of 31 December 2024 is -1.22.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2024-12-31	-1.22
2024-09-30	-1.07	-1.07
2024-06-30	-0.90	-0.90
2024-03-31	-1.05	-1.05
2023-12-31	-1.22
2023-09-30	-1.27	-1.27
2023-06-30	-1.32	-1.32
2023-03-31	-1.33	-1.33
2022-12-31	-1.35
2022-09-30	-1.34	-1.34
2022-06-30	-1.32	-1.32
2022-03-31	-1.31	-1.31
2021-12-31	-1.30
2021-09-30	-1.29	-1.29
2021-06-30	-1.29	-1.29
2021-03-31	-1.27	-1.27
2020-12-31	-1.25
2020-09-30	-1.24	-1.24
2020-06-30	-1.23	-1.23

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Sequana Medical NV as of 31 December 2024 is -20.26 MM.
The cash from investing activities for Sequana Medical NV as of 31 December 2024 is -0.10 MM.
The cash from financing activities for Sequana Medical NV as of 31 December 2024 is 21.56 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2024-12-31	-20.26	-0.10	21.56
2024-09-30	-22.66	-0.38	17.13
2024-06-30	-25.06	-0.67	12.70
2024-03-31	-27.06	-0.70	13.08
2023-12-31	-29.06	-0.72	13.46
2023-09-30	-29.62	-0.51	18.64
2023-06-30	-30.19	-0.29	23.82
2023-03-31	-28.83	-0.47	30.57
2022-12-31	-27.48	-0.65	37.32
2022-09-30	-26.45	-0.68	32.68
2022-06-30	-25.41	-0.71	28.03
2022-03-31	-24.51	-0.52	25.23
2021-12-31	-23.62	-0.34	22.44
2021-09-30	-21.62	-0.26	24.51
2021-06-30	-19.63	-0.18	26.59
2021-03-31	-18.32	-0.16	24.61
2020-12-31	-17.01	-0.14	22.63
2020-09-30	-16.27	-0.07	20.21
2020-06-30

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Sequana Medical NV as of 31 December 2024 is -6.33.
The p/book for Sequana Medical NV as of 31 December 2024 is -8.79.
The p/tbv for Sequana Medical NV as of 31 December 2024 is -8.79.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2024-12-31	-6.33	-8.79	-8.79
2024-09-30	-1.17
2024-06-30	-1.29	-2.16	-2.16
2024-03-31	-1.36
2023-12-31	-3.41	-30.59	-30.59
2023-09-30
2023-06-30	-3.02	-43.21	-43.21
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31	-6.55	12.86	13.15
2021-09-30	-5.54	10.89	11.13
2021-06-30	-5.32	10.45	10.68
2021-03-31	-5.61	10.42	10.66
2020-12-31	-5.07	859.17	-794.75
2020-09-30	-5.33	859.17	-794.75
2020-06-30	-5.62	10.17	10.35

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Sequana Medical NV as of 31 December 2024 is -0.14.
The ebit (3y)/ev for Sequana Medical NV as of 31 December 2024 is -0.16.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2024-12-31	-0.14	-0.16
2024-09-30	-0.84	-0.81
2024-06-30	-0.57	-0.52
2024-03-31	-0.73	-0.47
2023-12-31	-0.29	-0.25
2023-09-30	-0.41	-0.34
2023-06-30	-0.32	-0.27
2023-03-31	-0.27	-0.15
2022-12-31	-0.21	-0.17
2022-09-30	-0.19	-0.16
2022-06-30	-0.19	-0.16
2022-03-31	0.00	-0.08
2021-12-31	-0.17	-0.15
2021-09-30	-0.20	-0.18
2021-06-30	-0.21	-0.18
2021-03-31	-0.20	-0.17
2020-12-31	-0.20	-0.17
2020-09-30	-0.19	-0.16
2020-06-30	-0.19	-0.16

Management Effectiveness

The roa for Sequana Medical NV as of 31 December 2024 is -2.69.
The roic for Sequana Medical NV as of 31 December 2024 is -9.81.
The croic for Sequana Medical NV as of 31 December 2024 is -4.68.
The ocroic for Sequana Medical NV as of 31 December 2024 is -9.04.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2024-12-31	-2.69		-9.81	-4.68	-9.04
2024-09-30	-3.22
2024-06-30	-1.30
2024-03-31	-1.24
2023-12-31	-1.24		-2.31	-0.82	-2.11
2023-09-30	-1.05	-2.49	-2.31	-0.48	-2.15
2023-06-30	-1.00	-2.37	-1.76	-0.36	-1.64
2023-03-31		-2.43	-2.27	0.09	-2.07
2022-12-31	-1.81		-4.52	0.89	-4.17
2022-09-30	-1.81		-4.52	0.89	-4.17
2022-06-30	-0.92	-2.43	-1.24	0.09	-1.19
2022-03-31	0.00	0.00	0.00
2021-12-31	-1.51	-209.43	-3.34	-0.20	-1.07
2021-09-30	-1.59	-199.79	-3.19	0.39	-1.07
2021-06-30	-1.17	-2.25	-1.17	0.38	-1.07
2021-03-31	-1.11	-2.13	-1.10	0.34	-1.00
2020-12-31	-2.04	-20.63	-1.75	0.50	-1.56
2020-09-30	-1.94	-19.62	-1.66	0.34	-1.49
2020-06-30	-1.07	-2.01	-1.13	0.13	-1.02

Gross Margins

The gross margin for Sequana Medical NV as of 31 December 2024 is 0.77.
The net margin for Sequana Medical NV as of 31 December 2024 is -62.70.
The operating margin for Sequana Medical NV as of 31 December 2024 is -54.60.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2024-12-31	0.77	-62.70	-54.60
2024-09-30	0.77	-45.74	-41.42
2024-06-30	0.77	-45.74	-41.42
2024-03-31	0.77	-38.43	-36.51
2023-12-31	0.77	-38.43	-36.51
2023-09-30	0.77	-38.43	-36.51
2023-06-30	0.78	-38.43	-36.51
2023-03-31	0.78	-35.77	-33.64
2022-12-31	0.78	-33.04	-30.56
2022-09-30	0.78	-33.04	-30.56
2022-06-30	0.79	-32.72	-30.05
2022-03-31		0.00	-39.76
2021-12-31	0.79	-63.65	-60.95
2021-09-30	0.79	-59.12	-56.34
2021-06-30	0.79	-54.82	-51.97
2021-03-31	0.79	-29.94	-28.13
2020-12-31	0.79	-19.83	-18.45
2020-09-30	0.79	-17.17	-15.99
2020-06-30	0.79	-14.95	-13.46

US:SQNMF
DE:2SE	1,00 €
GB:SEQUAB